{"title":"Visual and health-related quality of life in cataract patients versus healthy controls.","authors":"Aryan Miraftab, Leila Ghiasian, Masood Naseripour","doi":"10.18240/ijo.2025.10.09","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To compare health-related quality of life and vision-related quality of life between patients with cataracts and healthy controls.</p><p><strong>Methods: </strong>This research was carried out as a cross-sectional study. Participants were selected from Rasoul Akram Hospital in Tehran, Iran, comprised of two groups: healthy individuals and those diagnosed with cataracts, using a simple random sampling technique. Following the interviews, participants completed the SF-36 health-related quality of life questionnaire and the VFQ-25 vision-related quality of life questionnaire. Comprehensive optometric and ophthalmic assessments, were conducted for all participants.</p><p><strong>Results: </strong>This research involved a selection of 130 healthy individuals and 154 cataract patients who were candidates for cataract surgery. The average ages of the healthy individuals and cataract patients were 69.7±3.5 and 69.5±6.5y, respectively (<i>P</i>=0.837), with 42.3% of the healthy individuals and 44.8% of the cataract male patients (<i>P</i>=0.672). According to the SF-36 questionnaire, the quality of life regarding physical functioning, role limitations due to physical health, social functioning, pain, and general health were significantly worse among cataract patients. The composite physical index for cataract patients and healthy individuals was 70.7±9.08 and 78.53±8.17, respectively (<i>P</i><0.001; effect size=0.90, 95%CI: 0.66-1.15), while the mental index showed no significant difference between the two groups (<i>P</i>=0.112; effect size=0.19, 95%CI: -0.04-0.42). All aspects of the VFQ-25 questionnaire were notably lower in cataract patients, with the mean final VFQ-25 scores being 56.49±14.81 for cataract patients and 92.9±4.64 for healthy individuals (<i>P</i><0.001; effect size=3.21, 95%CI: 2.85-3.56). The VFQ-25 questionnaire indicated that the most significant effect size was associated with role difficulties and distance activities. More components from both questionnaires exhibited a substantial correlation with best-corrected visual acuity in cataract patients.</p><p><strong>Conclusion: </strong>Patients suffering from cataracts exhibit a significantly reduced health-related quality of life, especially concerning physical health and vision-related quality of life, compared to those without cataracts. Timely surgical treatment for these individuals can improve their overall quality of life.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 10","pages":"1880-1887"},"PeriodicalIF":1.8000,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454001/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.10.09","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To compare health-related quality of life and vision-related quality of life between patients with cataracts and healthy controls.
Methods: This research was carried out as a cross-sectional study. Participants were selected from Rasoul Akram Hospital in Tehran, Iran, comprised of two groups: healthy individuals and those diagnosed with cataracts, using a simple random sampling technique. Following the interviews, participants completed the SF-36 health-related quality of life questionnaire and the VFQ-25 vision-related quality of life questionnaire. Comprehensive optometric and ophthalmic assessments, were conducted for all participants.
Results: This research involved a selection of 130 healthy individuals and 154 cataract patients who were candidates for cataract surgery. The average ages of the healthy individuals and cataract patients were 69.7±3.5 and 69.5±6.5y, respectively (P=0.837), with 42.3% of the healthy individuals and 44.8% of the cataract male patients (P=0.672). According to the SF-36 questionnaire, the quality of life regarding physical functioning, role limitations due to physical health, social functioning, pain, and general health were significantly worse among cataract patients. The composite physical index for cataract patients and healthy individuals was 70.7±9.08 and 78.53±8.17, respectively (P<0.001; effect size=0.90, 95%CI: 0.66-1.15), while the mental index showed no significant difference between the two groups (P=0.112; effect size=0.19, 95%CI: -0.04-0.42). All aspects of the VFQ-25 questionnaire were notably lower in cataract patients, with the mean final VFQ-25 scores being 56.49±14.81 for cataract patients and 92.9±4.64 for healthy individuals (P<0.001; effect size=3.21, 95%CI: 2.85-3.56). The VFQ-25 questionnaire indicated that the most significant effect size was associated with role difficulties and distance activities. More components from both questionnaires exhibited a substantial correlation with best-corrected visual acuity in cataract patients.
Conclusion: Patients suffering from cataracts exhibit a significantly reduced health-related quality of life, especially concerning physical health and vision-related quality of life, compared to those without cataracts. Timely surgical treatment for these individuals can improve their overall quality of life.
期刊介绍:
· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication
and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).
This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from
WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,
PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.
IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific
Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);
Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,
Chinese Academy of Engineering.
International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of
blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of
AAO/PAAO) et al.
Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of
Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and
Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).
Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).
Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).
Associate Editors-in-Chief include:
Prof. Ning-Li Wang (President Elect of APAO);
Prof. Ke Yao (President of Chinese Ophthalmological Society) ;
Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;
Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);
Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);
Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);
Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).
IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,
both basic and clinical papers.
Instruction is Welcome Contribution is Welcome Citation is Welcome
Cooperation organization
International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.